Virtual Posters & Abstracts

Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2023 Lymphoma, Leukemia & Myeloma Congress. 

  • Increase Your Research Engagement. Seize the opportunity to present your work to more than 1,000+ attendees at one of the most respected forums for industry-leading hematologic research and clinical case studies.
  • Get Published. Accepted abstracts will be published in the American Journal of Hematology and shared on the Oncology Learning Network.
  • Receive Accolades. Each year the Congress Chairs recognize the “Best Of” submitted abstracts. Winning abstracts receive free congress registration.

Accepted abstracts will be published in the American Journal of Hematology and shared with attendees as digital posters accessible online. Only abstracts received by the submission deadline will be published.

Important Abstract Dates

Abstract Submission Deadline

August 15, 2023, 11:59 PM ET

Abstract Notifications Mailed

on or before September 15, 2023

Abstract Withdrawal Deadline

September 21, 2023

Abstract Presenter Registration Deadline

October 5, 2023

Upload Poster PDF Deadline

October 11, 2023

Poster Display Dates

October 18-21, 2023

Abstracts will be accepted in the following categories: Acute Leukemia & Myeloproliferative/Myelodysplastic Diseases, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Lymphoma


    Abstract Categories

    Acute Leukemia & Myeloproliferative/Myelodysplatic Diseases  

    A1. Clinical Trials
    A2. Procedures and Diagnostics
    A3. Epidemiology and Outcomes Research
    A4. Clinical Case Reports

    Multiple Myeloma

    M1. Clinical Trials
    M2. Procedures and Diagnostics
    M3. Epidemiology and Outcomes Research
    M4. Clinical Case Reports

    Chronic Lymphocytic Leukemia

    C1. Clinical Trials
    C2. Procedures and Diagnostics
    C3. Epidemiology and Outcomes Research
    C4. Clinical Case Reports


    L1. Clinical Trials
    L2. Procedures and Diagnostics
    L3. Epidemiology and Outcomes Research
    L4. Clinical Case Reports

    Clinical Trials in Progress*

    L1. Trials in Progress in Leukemia
    L2. Trials in Progress in Lymphoma
    L3. Trials in Progress in Myeloma
    L4. Trials in Progress in CLL

    * Please submit all trials in progress in this category